Tarsus Pharmaceuticals, Inc. ($TARS)
Filing Information
| Accession Number | 0001405253-26-000013 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 17, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
70,158
Total Value
$877,436.20
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer and Chief Strategy Officer | Common Stock | โ | Jun 15, 2026 | Exercise/Conversion | 27,881 | โ | โ | 71,197 | Direct | โ | View Details | |
Chief Financial Officer and Chief Strategy Officer | Common Stock | โ | Jun 16, 2026 | Sale | 14,396 | $60.95 | $877,436.20 | 56,801 | Direct | โ | View Details | |
Chief Financial Officer and Chief Strategy Officer | Restricted Stock Units | Derivative | Jun 15, 2026 | Exercise/Conversion | 27,881 | $0.00 | $0.00 | 27,882 | Direct | โ | View Details |